Transcriptomics

Dataset Information

0

Melatonin inhibits fibroblast cell functions and hypertrophic scar formation by enhancing autophagy through the MT2 receptor-inhibited PI3K/Akt /mTOR signaling


ABSTRACT: Hypertrophic scar (HS) is a fibrotic skin condition and characterized by abnormal proliferation of myofibroblasts and accumulation of extracellular matrix. Melatonin, an endogenous hormone, can alleviate fibrosis in multiple models of diseases. This study examined the effect of melatonin on fibrosis in primary fibroblasts from human HS (HSFs) and a rabbit ear model and potential mechanisms. Melatonin treatment significantly decreased the migration and contraction capacity, collagen and α-smooth muscle actin (α-SMA) production in HSFs. RNA-sequencing and bioinformatic analyses indicated that melatonin modulated the expression of genes involved in autophagy and oxidative stress. Mechanistically, melatonin treatment attenuated the AKT/mTOR activation through affecting the binding of MT2 receptor with PI3K to enhance autophagy, decreasing fibrogenic factor production in HSFs. Moreover, melatonin treatment inhibited HS formation in rabbit ears by enhancing autophagy. The anti-fibrotic effects of melatonin were abrogated by treatment with an autophagy inhibitor (3-methyladenine, 3-MA), an Akt activator (SC79), or an MT2 selective antagonist (4-phenyl-2propionamidotetralin, 4-P-PDOT). Therefore, melatonin may be a potential drug for prevention and treatment of HS.

ORGANISM(S): Homo sapiens

PROVIDER: GSE190135 | GEO | 2022/06/03

REPOSITORIES: GEO

Similar Datasets

| PRJNA785978 | ENA
2022-10-26 | GSE201943 | GEO
2013-02-22 | E-GEOD-44477 | biostudies-arrayexpress
2013-02-22 | E-GEOD-44470 | biostudies-arrayexpress
2016-10-05 | GSE77678 | GEO
| PRJNA445729 | ENA
2023-07-15 | GSE236983 | GEO
2021-11-22 | GSE189134 | GEO
2010-03-09 | E-GEOD-18604 | biostudies-arrayexpress
2014-08-01 | E-GEOD-56611 | biostudies-arrayexpress